EMEA-002116-PIP01-17

Key facts

Active substance
Insulin human (NTRA-2112)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0079/2018
PIP number
EMEA-002116-PIP01-17
Pharmaceutical form(s)
Powder for oral solution
Condition(s) / indication(s)
Treatment of intestinal malabsorption in preterm infants
Route(s) of administration
Oral use
Contact for public enquiries
Nutrinia, Ltd.
Tel. +972 37262262
E-mail: info@nutrinia.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating